End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.54 CNY | +6.36% | -9.85% | -33.19% |
26/04 | Shaanxi Kanghui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
15/03 | Kanghui Pharmaceutical to Earn 151 Million Yuan from Kelavi Buyback | MT |
1st Jan change | Capi. | |
---|---|---|
-33.19% | 17Cr | |
+20.14% | 4.33TCr | |
+23.67% | 2.22TCr | |
+16.89% | 1.54TCr | |
+23.10% | 1.45TCr | |
+57.58% | 1.27TCr | |
-0.05% | 678.76Cr | |
-10.69% | 670.81Cr | |
-8.87% | 572.55Cr | |
+14.68% | 549.79Cr |
- Stock Market
- Equities
- 603139 Stock
- News Shaanxi Kanghui Pharmaceutical Co., Ltd.
- Hubei Klavi Biopharmaceutical Co., Ltd. announced that it has received CNY 50.4 million in funding from Shaanxi Kanghui Pharmaceutical Co., Ltd. and other investors